Medistri, a leading provider of contract sterilization & laboratory services for healthcare companies, is excited to announce the arrival of its fifth sterilization line on December 12. This investment of around 2 million CHF will allow Medistri to continue providing efficient and reliable sterilization services to a growing client base, with an increase in capacity. The new chamber will be used primarily for the sterilization of pharmaceutical & medical devices coming from multiple countries. It will be fully operational and ready to use by the begining of 2023.
“We are thrilled to be able to expand our sterilization capabilities with the addition of this new chamber,” said Medistri CEO Shoko Nilforoushan. “This significant investment will enable us to better serve our clients and further our mission of ensuring the safety and quality of sterilized products for customers across Europe.”
We are thrilled to be able to expand our sterilization capabilities with the addition of this new chamber
Shoko Nilforoushan, CEO of Medistri
Medistri has been providing sterilization & laboratory services for over 15 years and has since established itself as a trusted partner for companies in the pharmaceutical, medical device, aerospacial and biotechnology industries. The company is committed to using state-of-the-art technology and following strict sterilization guidelines to ensure the highest level of safety and effectiveness.
The new sterilization chamber will be located at Medistri’s headquarters in Domdidier.
